Endoglin (CD105) and proliferation index in recurrent glioblastoma treated with anti-angiogenic therapy

INTRODUCTION: CD105 is an angiogenic biomarker that is useful to determine the microvessel density (MVD) within a tumor, namely, in highly vascularized tumors like glioblastoma (GBM). However, its expression has shown inconsistent associations with the prognosis of GBM patients. The aim of this stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Bastos, António G. P., Carvalho, Bruno, Silva, Roberto, Leitão, Dina, Linhares, Paulo, Vaz, Rui, Lima, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486379/
https://www.ncbi.nlm.nih.gov/pubmed/36147918
http://dx.doi.org/10.3389/fonc.2022.910196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9486379/
https://www.ncbi.nlm.nih.gov/pubmed/36147918
http://dx.doi.org/10.3389/fonc.2022.910196

Ejemplares similares